(Hypertension. 1999;33:396-401.)
© 1999 American Heart Association, Inc.
Scientific Contribution |
1-Adrenergic Stimulation
Correspondence to Walter J. Koch, PhD, Department of Surgery, Duke University Medical Center, Room 472, MSRB, Research Drive, Durham, NC 27710. E-mail koch0002{at}mc.duke.edu
AbstractPressure overload
ventricular hypertrophy is accompanied by
dysfunctional ß-adrenergic receptor signaling due to increased levels
of the ß-adrenergic receptor kinase-1, which
phosphorylates and desensitizes ß-adrenergic receptors.
In this study, we examined whether increased ß-adrenergic receptor
kinase 1 expression is associated with myocardial
hypertrophy induced by adrenergic stimulation. With use of
implanted mini-osmotic pumps, we treated mice with isoproterenol,
phenylephrine, or vehicle to distinguish between
1- and ß-adrenergic stimulation. Both treatments
resulted in cardiac hypertrophy, but only isoproterenol
induced significant increases in ß-adrenergic receptor kinase-1
protein levels and activity. Similarly, in isolated adult rat cardiac
myocytes, 24 hours of isoproterenol stimulation resulted in a
significant 2.8-fold increase in ß-adrenergic receptor kinase-1
protein levels, whereas 24 hours of phenylephrine treatment
did not alter ß-adrenergic receptor kinase-1 expression. Our results
indicate that increased ß-adrenergic receptor kinase-1 is not
invariably associated with myocardial hypertrophy but
apparently is controlled by the state of ß-adrenergic receptor
activation.
Key Words: myocardial hypertrophy ß-adrenergic receptor G proteincoupled receptor kinases desensitization catecholamines
This article has been cited by other articles:
![]() |
C. W. J. Melling, D. B. Thorp, K. J. Milne, M. P. Krause, and E. G. Noble Exercise-mediated regulation of Hsp70 expression following aerobic exercise training Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3692 - H3698. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leosco, G. Rengo, G. Iaccarino, A. Filippelli, A. Lymperopoulos, C. Zincarelli, F. Fortunato, L. Golino, M. Marchese, G. Esposito, et al. Exercise training and beta-blocker treatment ameliorate age-dependent impairment of beta-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1596 - H1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Campos, R. Iliescu, M. A. P. Fontes, W.-P. Schlegel, M. Bader, and O. C. Baltatu Enhanced isoproterenol-induced cardiac hypertrophy in transgenic rats with low brain angiotensinogen Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2371 - H2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Penela, C. Murga, C. Ribas, A. S. Tutor, S. Peregrin, and F. Mayor Jr. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease Cardiovasc Res, January 1, 2006; 69(1): 46 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iaccarino, E. Barbato, E. Cipolletta, V. De Amicis, K. B. Margulies, D. Leosco, B. Trimarco, and W. J. Koch Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure Eur. Heart J., September 1, 2005; 26(17): 1752 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, E. Sentex, H. K. Saini, D. Chapman, and N. S. Dhalla Upregulation of {beta}-adrenergic receptors in heart failure due to volume overload Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H151 - H159. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Leineweber, P. Rohe, A. Beilfuss, C. Wolf, H. Sporkmann, H. Bruck, H.-G. Jakob, G. Heusch, T. Philipp, and O.-E. Brodde G-protein-coupled receptor kinase activity in human heart failure: Effects of {beta}-adrenoceptor blockade Cardiovasc Res, June 1, 2005; 66(3): 512 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Leineweber, S. Klapproth, A. Beilfuss, R.-E. Silber, G. Heusch, T. Philipp, and O.-E. Brodde Unchanged G-protein-coupled receptor kinase activity in the aging human heart J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1487 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hata and W. J. Koch Phosphorylation of G Protein-Coupled Receptors: GPCR Kinases in Heart Disease Mol. Interv., August 1, 2003; 3(5): 264 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Keys, E. A. Greene, W. J. Koch, and A. D. Eckhart Gq-Coupled Receptor Agonists Mediate Cardiac Hypertrophy Via the Vasculature Hypertension, November 1, 2002; 40(5): 660 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Condorelli, A. Drusco, G. Stassi, A. Bellacosa, R. Roncarati, G. Iaccarino, M. A. Russo, Y. Gu, N. Dalton, C. Chung, et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice PNAS, September 17, 2002; 99(19): 12333 - 12338. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Leineweber, I. Heinroth-Hoffmann, K. Ponicke, G. Abraham, B. Osten, and O.-E. Brodde Cardiac {beta}-Adrenoceptor Desensitization Due to Increased {beta}-Adrenoceptor Kinase Activity in Chronic Uremia J. Am. Soc. Nephrol., January 1, 2002; 13(1): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iaccarino, J. R. Keys, A. Rapacciuolo, K. F. Shotwell, R. J. Lefkowitz, H. A. Rockman, and W. J. Koch Regulation of myocardial {beta}ARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing {alpha}1B-adrenergic receptors J. Am. Coll. Cardiol., August 1, 2001; 38(2): 534 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iaccarino, E. Barbato, E. Cipolleta, A. Esposito, A. Fiorillo, W. J. Koch, and B. Trimarco Cardiac {beta}ARK1 Upregulation Induced by Chronic Salt Deprivation in Rats Hypertension, August 1, 2001; 38(2): 255 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Muth, I. Bodi, W. Lewis, G. Varadi, and A. Schwartz A Ca2+-Dependent Transgenic Model of Cardiac Hypertrophy : A Role for Protein Kinase C{{alpha}} Circulation, January 2, 2001; 103(1): 140 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Manning, K. Shotwell, L. Mao, H. A. Rockman, and W. J. Koch Physiological Induction of a {beta}-Adrenergic Receptor Kinase Inhibitor Transgene Preserves {beta}-Adrenergic Responsiveness in Pressure-Overload Cardiac Hypertrophy Circulation, November 28, 2000; 102(22): 2751 - 2757. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Sheridan, D. J. Autelitano, B. Wang, E. Percy, E. A. Woodcock, and X.-J. Du {beta}2-Adrenergic receptor overexpression driven by {alpha}-MHC promoter is downregulated in hypertrophied and failing myocardium Cardiovasc Res, July 1, 2000; 47(1): 133 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lipskaia, N. Defer, G. Esposito, I. Hajar, M.-C. Garel, H. A. Rockman, and J. Hanoune Enhanced Cardiac Function in Transgenic Mice Expressing a Ca2+-Stimulated Adenylyl Cyclase Circ. Res., April 14, 2000; 86(7): 795 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Eckhart, S. J. Duncan, R. B. Penn, J. L. Benovic, R. J. Lefkowitz, and W. J. Koch Hybrid Transgenic Mice Reveal In Vivo Specificity of G Protein-Coupled Receptor Kinases in the Heart Circ. Res., January 7, 2000; 86(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Antos, N. Frey, S. O. Marx, S. Reiken, M. Gaburjakova, J. A. Richardson, A. R. Marks, and E. N. Olson Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A Circ. Res., November 23, 2001; 89(11): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |